Prostate PSA Test: What Your Score Means and What Comes Next

What Is a PSA Test?

A PSA test measures prostate-specific antigen, a protein made by the prostate gland, in your blood. Small amounts of PSA normally leak into the bloodstream. Higher amounts can signal prostate cancer, but also benign prostate enlargement, infection, or recent prostate irritation.

The test is a simple blood draw. A related measure, the free-to-total PSA ratio, compares unbound PSA to total PSA and can help refine decisions when total PSA sits in the borderline zone. This is educational information, not medical advice, and screening choices should be made with a clinician.

Why a PSA Test Is Ordered

• Prostate cancer screening in men, usually starting around age 50, or earlier with risk factors
• Urinary symptoms such as weak stream, urgency, or nighttime urination
• Monitoring known prostate enlargement or prostatitis
• Follow-up after prostate cancer treatment
• Family history of prostate cancer or known high-risk background

Guidelines differ on when to start screening, so age, family history, and personal preference all feed into the decision.

Normal PSA Range

There is no single cutoff, and ranges vary by laboratory. Commonly used reference points are:

Many clinicians still use 4.0 ng/mL as a general discussion threshold, but age-adjusted ranges are increasingly common. Always use your own lab reference range.

What a High PSA Means

A raised PSA does not equal cancer. Common non-cancer causes include benign prostatic hyperplasia, prostatitis, urinary tract infection, recent ejaculation, vigorous cycling, or a recent prostate exam or biopsy. Each of these can push PSA up temporarily.

When PSA is persistently high, clinicians look at the trend over time (PSA velocity), prostate size, the free-to-total ratio, and sometimes MRI before recommending biopsy. A low free-to-total ratio is more concerning than a high one.

Free-to-Total PSA Ratio

PSA circulates in free and protein-bound forms. When total PSA is borderline, roughly 4 to 10 ng/mL, the ratio helps sort risk. A free PSA above about 25 percent of total leans toward benign causes, while a ratio below about 10 to 15 percent raises more concern and often prompts closer follow-up.

The ratio is a risk tool, not a diagnosis. It is interpreted alongside age, trend, exam findings, and imaging.

How to Order a PSA Test and Where to Get Tested

You can get a PSA test through a clinician or through direct-access lab testing, where you order online and visit a local collection site. Avoid ejaculation for about 48 hours before the draw, and tell the lab about recent prostate exams, biopsies, infections, or urinary symptoms.

If your total PSA comes back borderline, consider adding the free-to-total PSA ratio so the follow-up conversation with your clinician is better informed.

How Much Does a PSA Test Cost?

Direct-access PSA testing commonly costs between about $40 and $90. Adding the free-to-total ratio usually brings the total to about $80 to $150. Bundled men's health panels cost more but cover cholesterol, testosterone, and metabolic markers in the same draw.

Screening PSA is covered by many insurance plans at recommended ages, but direct-access testing is a practical option for anyone who wants results without an office visit. Confirm whether collection fees are included in the quoted price.

Factors That Can Shift PSA Results

PSA is sensitive to prostate irritation of any kind. Ejaculation within 48 hours, vigorous cycling, a recent urinary infection, a prostate exam, or a biopsy can all raise the number temporarily. Some drugs for prostate enlargement, such as finasteride and dutasteride, roughly halve PSA, so the result is often doubled for interpretation.

Because of this noise, clinicians rarely act on a single borderline value. Repeating the test after avoiding known triggers, then watching the trend across months, separates meaningful rises from passing fluctuations.

PSA Screening Decisions by Age and Risk

Screening conversations usually start around age 50 for average risk men, earlier with a family history of prostate cancer or African ancestry. Men with limited life expectancy often skip screening since slow growing cancers may never cause harm. Your preferences about biopsy and treatment matter as much as the number, so discuss the tradeoffs openly with your clinician.